Alzheimers Disease

Watching a lot of TV in midlife tied to reduced brain health later on | Carrick Pharmacy

(Carrick Pharmacy News) That nightly TV binge might be harming your brain. According to new research, watching moderate to high amounts of TV in middle age appears to be tied to reduced cognitive function and smaller volumes of gray matter later in life. That suggests that your lifestyle choices in midlife could have real impacts …

Watching a lot of TV in midlife tied to reduced brain health later on | Carrick Pharmacy Read More »

Watching a lot of TV in midlife tied to reduced brain health later on | RxWiki

Here’s what you need to know about Alzheimer’s disease | Carrick Pharmacy

(Carrick Pharmacy News) An estimated 5.8 million people in the United States are living with Alzheimer’s, according to the Centers for Disease Control and Prevention. To boost your Alzheimer’s awareness, take a look at the information below. Here’s what you should know. What Is Alzheimer’s Disease? Alzheimer’s disease is the most common type of dementia. …

Here’s what you need to know about Alzheimer’s disease | Carrick Pharmacy Read More »

Here's what you need to know about Alzheimer's disease | RxWiki

FDA approves Lumipulse test to look for early signs of Alzheimer’s disease | Carrick Pharmacy

(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved a first-of-its-kind test to diagnose Alzheimer’s disease. This test is called the Lumipulse G β-Amyloid Ratio (1-42/1-40) test. The FDA approved it for use in those for whom all of the following points are true: 55 years and older Under evaluation …

FDA approves Lumipulse test to look for early signs of Alzheimer’s disease | Carrick Pharmacy Read More »

FDA approves Lumipulse test to look for early signs of Alzheimer’s disease | RxWiki

FDA approves Adlarity (donepezil) to treat Alzheimer’s disease | Carrick Pharmacy

(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved a once-weekly patch for Alzheimer’s disease. This patch is found under the brand name Adlarity with the active ingredient donepezil. Donepezil is the active ingredient of Aricept, which has been on the market to treat Alzheimer’s for about 26 years. However, Aricept is …

FDA approves Adlarity (donepezil) to treat Alzheimer’s disease | Carrick Pharmacy Read More »

FDA approves Adlarity (donepezil) to treat Alzheimer's disease | RxWiki
Scroll to Top
Scroll to Top